A chitosan-based cascade-responsive drug delivery system for triple-negative breast cancer therapy

It is extremely difficult to develop targeted treatments for triple-negative breast (TNB) cancer, because these cells do not express any of the key biomarkers usually exploited for this goal.
Source: Journal of Nanobiotechnology - Category: Nanotechnology Authors: Tags: Research Source Type: research